| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 51,845 | 57,857 | ||
| Restricted cash | 110 | 110 | ||
| Prepaid materials | 3,143 | 3,475 | ||
| Prepaid expenses and other current assets | 580 | 1,075 | ||
| Total current assets | 55,678 | 62,517 | ||
| Other assets | 2,334 | 1,998 | ||
| Total assets | 58,012 | 64,515 | ||
| Accounts payable | 3,536 | 2,010 | ||
| Accrued expenses | 1,989 | 2,200 | ||
| Payroll liabilities | 1,125 | 1,054 | ||
| Other current liabilities | 1,575 | 1,556 | ||
| Total current liabilities | 8,225 | 6,820 | ||
| Total liabilities | 8,225 | 6,820 | ||
| Common stock - 0.18 par value 350,000,000 shares authorized 129,171,424 and 129,170,004 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 23,488 | 23,488 | ||
| Additional paid-in capital | 263,399 | 262,615 | ||
| Treasury stock, at cost 1,320,046 shares of common stock at september 30, 2025 and december 31, 2024 | 1,475 | 1,475 | ||
| Accumulated deficit | -235,625 | -226,933 | ||
| Total stockholders' equity | 49,787 | 57,695 | ||
| Total liabilities and stockholders' equity | 58,012 | 64,515 | ||
ATOSSA THERAPEUTICS, INC. (ATOS)
ATOSSA THERAPEUTICS, INC. (ATOS)